Edition:
United States

People: Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,468JPY
28 Apr 2017
Change (% chg)

¥-48 (-3.17%)
Prev Close
¥1,516
Open
¥1,497
Day's High
¥1,500
Day's Low
¥1,455
Volume
16,371,000
Avg. Vol
7,335,467
52-wk High
¥1,779
52-wk Low
¥1,415

Hatanaka, Yoshihiko 

Mr. Yoshihiko Hatanaka has been serving as President, Chief Executive Officer, Chairman of the Board of Directors and Representative Director in Astellas Pharma Inc. since June 20, 2016. His previous titles include Executive Officer and Senior Executive Officer in the Company. He previously served as President and Chief Executive Officer in two US-based subsidiaries. He used to work for Fujisawa Pharmaceutical Co., Ltd. He obtained his bachelor's degree in Economics from Hitotsubashi University in May 1980.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --